BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 30344417)

  • 1. Management of bacterial and fungal infections in end stage liver disease and liver transplantation: Current options and future directions.
    Righi E
    World J Gastroenterol; 2018 Oct; 24(38):4311-4329. PubMed ID: 30344417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial and fungal infections in the early post-transplantation period after liver transplantation: etiologic agents and their susceptibility.
    Kawecki D; Pacholczyk M; Lagiewska B; Sawicka-Grzelak A; Durlik M; Mlynarczyk G; Chmura A
    Transplant Proc; 2014 Oct; 46(8):2777-81. PubMed ID: 25380916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug-resistant bacterial infections after liver transplantation: an ever-growing challenge.
    Santoro-Lopes G; de Gouvêa EF
    World J Gastroenterol; 2014 May; 20(20):6201-10. PubMed ID: 24876740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of infections in patients with cirrhosis in the context of increasing therapeutic resistance: A systematic review.
    Allaire M; Cadranel JF; Nguyen TTN; Garioud A; Zougmore H; Heng R; Perignon C; Ollivier-Hourmand I; Dao T
    Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):264-274. PubMed ID: 31706985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug-Resistant Bacteria and Disease Progression in Patients with End-Stage Liver Disease and after Liver Transplantation.
    Friedrich K; Krempl J; Schamoni S; Hippchen T; Pfeiffenberger J; Rupp C; Gotthardt DN; Houben P; Von Haken R; Heininger A; Brenner T; Mehrabi A; Weiss KH; Mieth M
    J Gastrointestin Liver Dis; 2019 Sep; 28(3):303-310. PubMed ID: 31517327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inadequate antibiotic therapy in solid organ transplant recipients is associated with a higher mortality rate.
    Lupei MI; Mann HJ; Beilman GJ; Oancea C; Chipman JG
    Surg Infect (Larchmt); 2010 Feb; 11(1):33-9. PubMed ID: 19785562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor-derived infections among Chinese donation after cardiac death liver recipients.
    Ye QF; Zhou W; Wan QQ
    World J Gastroenterol; 2017 Aug; 23(31):5809-5816. PubMed ID: 28883707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant Enterococcus: Three major threats to hematopoietic stem cell transplant recipients.
    Satlin MJ; Walsh TJ
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28815897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective analysis of the use of caspofungin in recipients of liver transplant with a modified high index of suspicion for fungal infection. A critical review of mortality, acute cellular rejection, infections, and changes in the liver function tests while on caspofungin.
    Doria C; Bodzin AS; Vaccino S; Daskalakis C; Krawitz S; Ramirez CB
    Clin Transplant; 2011; 25(4):569-75. PubMed ID: 20662881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive fungal infections following liver transplantation: incidence, risk factors, survival, and impact of fluconazole-resistant Candida parapsilosis (2003-2007).
    Raghuram A; Restrepo A; Safadjou S; Cooley J; Orloff M; Hardy D; Butler S; Koval CE
    Liver Transpl; 2012 Sep; 18(9):1100-9. PubMed ID: 22577087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial infections in hematopoietic stem cell transplantation recipients.
    Mikulska M; Del Bono V; Viscoli C
    Curr Opin Hematol; 2014 Nov; 21(6):451-8. PubMed ID: 25295742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiological findings of culture-positive preservation fluid in liver transplantation.
    Janny S; Bert F; Dondero F; Durand F; Guerrini P; Merckx P; Nicolas-Chanoine MH; Belghiti J; Mantz J; Paugam-Burtz C
    Transpl Infect Dis; 2011 Feb; 13(1):9-14. PubMed ID: 20738832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection among adult small bowel and multivisceral transplant recipients in the 30-day postoperative period.
    Primeggia J; Matsumoto CS; Fishbein TM; Karacki PS; Fredette TM; Timpone JG
    Transpl Infect Dis; 2013 Oct; 15(5):441-8. PubMed ID: 23809406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel strategies for the management of bacterial and fungal infections in patients with liver cirrhosis: focus on new antimicrobials.
    Maraolo AE; Scotto R; Zappulo E; Pinchera B; Schiano Moriello N; Nappa S; Buonomo AR; Gentile I
    Expert Rev Anti Infect Ther; 2020 Mar; 18(3):191-202. PubMed ID: 32011191
    [No Abstract]   [Full Text] [Related]  

  • 15. [Microbial spectrum in surgical infections based on a microbiological routine monitoring over the 10-year period from 1995 to 2004].
    Mroczkowski P; Lauf H; Lippert H; König W; Meyer F
    Zentralbl Chir; 2009 Jun; 134(3):226-30. PubMed ID: 19536716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbapenem-Resistant Klebsiella pneumoniae influences the outcome of early infections in liver transplant recipients.
    Barchiesi F; Montalti R; Castelli P; Nicolini D; Staffolani S; Mocchegiani F; Fiorentini A; Manso E; Vivarelli M
    BMC Infect Dis; 2016 Oct; 16(1):538. PubMed ID: 27716164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide.
    Piano S; Singh V; Caraceni P; Maiwall R; Alessandria C; Fernandez J; Soares EC; Kim DJ; Kim SE; Marino M; Vorobioff J; Barea RCR; Merli M; Elkrief L; Vargas V; Krag A; Singh SP; Lesmana LA; Toledo C; Marciano S; Verhelst X; Wong F; Intagliata N; Rabinowich L; Colombato L; Kim SG; Gerbes A; Durand F; Roblero JP; Bhamidimarri KR; Boyer TD; Maevskaya M; Fassio E; Kim HS; Hwang JS; Gines P; Gadano A; Sarin SK; Angeli P;
    Gastroenterology; 2019 Apr; 156(5):1368-1380.e10. PubMed ID: 30552895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sepsis in Patients With Cirrhosis Awaiting Liver Transplantation: New Trends and Management.
    Martin Mateos R; Albillos A
    Liver Transpl; 2019 Nov; 25(11):1700-1709. PubMed ID: 31408581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for pneumonia caused by multidrug-resistant Gram-negative bacilli among liver recipients.
    Shi SH; Kong HS; Jia CK; Zhang WJ; Xu J; Wang WL; Shen Y; Zhang M; Zheng SS
    Clin Transplant; 2010; 24(6):758-65. PubMed ID: 20047611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of infections caused by multiple drug-resistant bacteria in liver transplant recipients.
    Gouvêa EF; Branco RC; Monteiro RC; Halpern M; Ribeiro-Filho J; Silveira VG; Tavares GC; Rodrigues MS; Coelho HS; Basto ST; Santoro-Lopes G
    Transplant Proc; 2004 May; 36(4):958-60. PubMed ID: 15194333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.